Hasil Pencarian - Julie R. Brahmer, MD
- Menampilkan 1 - 3 hasil dari 3
-
1
First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound Mutations oleh Tia Cheunkarndee, BA, Matthew Z. Guo, BA, Stefanie Houseknecht, PharmD, Josephine L. Feliciano, MD, Christine L. Hann, MD, PhD, Vincent K. Lam, MD, Benjamin P. Levy, MD, Joseph C. Murray, MD, PhD, Julie R. Brahmer, MD, Patrick M. Forde, MBBCh, Kristen A. Marrone, MD, Susan C. Scott, MD
Diterbitkan 2024-06-01Dapatkan teks lengkap
Artikel -
2
JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies oleh Julie R. Brahmer, MD, Melissa L. Johnson, MD, Manuel Cobo, MD, PhD, Santiago Viteri, MD, Juan Coves Sarto, MD, Ammar Sukari, MD, Mark M. Awad, MD, PhD, Ravi Salgia, MD, PhD, Vali A. Papadimitrakopoulou, MD, Arun Rajan, MD, Nibedita Bandyopadhyay, PhD, Alicia J. Allred, PhD, Mark Wade, MA, Gary E. Mason, MD, Enrique Zudaire, PhD, Roland E. Knoblauch, MD, PhD, Nicole Stone, PhD, Matthew V. Lorenzi, PhD, Raffit Hassan, MD
Diterbitkan 2021-02-01Dapatkan teks lengkap
Artikel -
3
Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC oleh Joshua E. Reuss, MD, Emily Brigham, MD, MHS, Kevin J. Psoter, PhD, Khinh Ranh Voong, MD, Bairavi Shankar, BS, David S. Ettinger, MD, Kristen A. Marrone, MD, Christine L. Hann, MD, Benjamin Levy, MD, Josephine L. Feliciano, MD, Julie R. Brahmer, MD, David Feller-Kopman, MD, Andrew D. Lerner, MD, Hans Lee, MD, Lonny Yarmus, DO, Russell K. Hales, MD, Franco D’Alessio, MD, Sonye K. Danoff, MD, PhD, Patrick M. Forde, MBBCH, Karthik Suresh, MD, Jarushka Naidoo, MBBCH, MHS
Diterbitkan 2021-10-01Dapatkan teks lengkap
Artikel